Not possible to specify

441 trials 102 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys? Recruiting

2023-510485-27-00 Kidney transplantation 6 2024-06-06
Safety, Tolerability, PK, PD, and Efficacy of HMB-001 in Participants With Glanzmann Thrombasthenia Recruiting

2023-505995-31-00 Glanzmann Thrombasthenia 7 2024-05-03
CARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA Recruiting

2023-503317-29-00 Metastatic renal cell carcinoma (mRCC) 5 2024-04-12
Phase 1b/2, Multicenter, Open-label, Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3-DXd m… Recruiting

2023-505925-15-00 Patients with HER2-positive (HER2-pos) (cohort 1) or HE 7 2024-03-21
DOUBLE PRO-TECT Alport: A confirmatory, multicenter, randomized, double-blind, placebo-controlled clinical trial to assess the effect of Dap… Recruiting

2023-508502-18-00 Alport syndrome 5 2024-03-19
Phase III, double-blind, randomised, placebo- and active treatment-controlled clinical trial to evaluate the analgesic efficacy and safety o… Recruiting

2023-505687-11-00 Acute pain 5 2024-02-06
Study aiming to assess the clinical impact of dostarlimab on occurrence of second primary cancer in patients with cured primary cancer Recruiting

2022-501316-34-00 Patient cured from a primary cancer and at risk of 2nd 4 2023-11-27
Randomized clinical study to analyse the effects of dapagliflozin on renal morphology and renal perfusion in patients with impaired renal f… Recruiting

2024-517885-40-00 Chronic Kidney Disease (CKD) 6 2023-07-03
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnorma… Recruiting

2022-501943-34-00 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 5 2023-06-27
A model of a sterile, self-limiting, acute inflammatory response in healthy volunteers using lipopolysaccharides – a platform trial Recruiting

2024-518768-11-02 Healthy volunteers 3 2023-05-19
A Phase 1 Study to Determine the Safety, and Pharmacokinetics of the Selective MET kinase Inhibitor, DO-2 in Patients With Advanced or Refra… Recruiting

2023-504897-39-00 Advanced or refractory solid tumours (Part 1) 1 2023-04-13
FORMA – a multicentre randomized-controlled trial to evaluate the efficacy and safety of ketoanalogues of essential amino acids in prophylax… Recruiting

2024-517880-22-00 Protein-energy wasting in nephrotic syndrome 5 2023-01-04
Window-of-opportunity proof-of-concept, non-randomized, open-label phase II trial of Olaparib given alone (cohort A) or in combination with … Recruiting

2024-511780-28-00 Patients with presumed and previously untreated advance 4 2022-05-05
EPO-TRAUMA Recruiting

2023-506081-31-00 Traumatic Injury 5 2022-03-29
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients Recruiting

2023-508594-84-00 Metastatic pancreatic adenocarcinoma 4 2022-01-11
CLEVER PEPTIDE : Open-label, non-controlled, multicenter, dose escalation, first-in-human clinical trial to evaluate the safety, pharmacokin… Recruiting

2024-518362-27-00 Patients with recurrent and/or metastatic solid cancer. 1 2021-05-18
Doxapram versus placebo in preterm newborns: An international double blinded multicenter randomized controlled trial Recruiting

2024-515625-29-00 Apnea of prematurity 5 2020-06-16
Investigation of neurobiological mechanisms of antidepressant action of ketamine using neuroimaging Recruiting

2024-519234-23-00 Healthy volunteers - no medical condition 3 2020-01-17
Study of clinical response, MRI progression, synovitis and changes in gene expression profiles in response to Sarilumab in patients with rhe… Recruiting

2024-514201-61-00 Rheumatoid arthritis 6 2019-12-10
A randomized phase II clinical trial on intratumoral AS01B/ipilimumab plus intravenous nivolumab with or without autologous CD1c(BDCA-1)+ / … Recruiting

2024-517094-24-00 Solid tumors 9 2018-01-08
A pilot study to assess the influence of drug transporters on brain and organ distribution of erlotinib in humans Recruiting

2024-516550-21-00 cancer 1 2015-06-26
Multiple-dose, open-label, laboratory blinded, randomized, 2-period, 2-sequence, crossover, steady-state bioequivalence study comparing the … Ended

2026-526102-33-00 No medical condition 2 2026-05-11
Bioequivalence clinical trial of two formulations of loperamide. Ended

2026-525278-20-00 Healthy volunteers 2 2026-05-05
Multiple-Dose Study in Healthy Participants Under Fasting Conditions to Evaluate the Bioequivalence of One Film-Coated Mini-Tablet of Indapa… Ended

2026-525823-26-00 No medical condition. 2 2026-04-25